375 related articles for article (PubMed ID: 26465200)
1. A Dietary Medium-Chain Fatty Acid, Decanoic Acid, Inhibits Recruitment of Nur77 to the HSD3B2 Promoter In Vitro and Reverses Endocrine and Metabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome.
Lee BH; Indran IR; Tan HM; Li Y; Zhang Z; Li J; Yong EL
Endocrinology; 2016 Jan; 157(1):382-94. PubMed ID: 26465200
[TBL] [Abstract][Full Text] [Related]
2. Does Dietary Fatty Acid, Decanoic Acid, Prevent Polycystic Ovary Syndrome?
Guo C
Endocrinology; 2016 Jan; 157(1):46-7. PubMed ID: 26717473
[No Abstract] [Full Text] [Related]
3. Cellular and Animal Studies: Insights into Pathophysiology and Therapy of PCOS.
Indran IR; Lee BH; Yong EL
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():12-24. PubMed ID: 27118251
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of human 3β-hydroxysteroid dehydrogenase type 2 for steroid hormone biosynthesis by starvation and cyclic AMP stimulation: studies in the human adrenal NCI-H295R cell model.
Udhane S; Kempna P; Hofer G; Mullis PE; Flück CE
PLoS One; 2013; 8(7):e68691. PubMed ID: 23874725
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2.
Kempná P; Hofer G; Mullis PE; Flück CE
Mol Pharmacol; 2007 Mar; 71(3):787-98. PubMed ID: 17138841
[TBL] [Abstract][Full Text] [Related]
6. The human 3beta-hydroxysteroid dehydrogenase/Delta5-Delta4 isomerase type 2 promoter is a novel target for the immediate early orphan nuclear receptor Nur77 in steroidogenic cells.
Martin LJ; Tremblay JJ
Endocrinology; 2005 Feb; 146(2):861-9. PubMed ID: 15498889
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain.
Hirsch A; Hahn D; Kempná P; Hofer G; Nuoffer JM; Mullis PE; Flück CE
Endocrinology; 2012 Sep; 153(9):4354-66. PubMed ID: 22778212
[TBL] [Abstract][Full Text] [Related]
8. Tetragonia tetragonioides (Pall.) Kuntze Regulates Androgen Production in a Letrozole-Induced Polycystic Ovary Syndrome Model.
Pyun BJ; Yang H; Sohn E; Yu SY; Lee D; Jung DH; Ko BS; Lee HW
Molecules; 2018 May; 23(5):. PubMed ID: 29757997
[No Abstract] [Full Text] [Related]
9. Baicalin inhibits recruitment of GATA1 to the HSD3B2 promoter and reverses hyperandrogenism of PCOS.
Yu J; Liu Y; Zhang D; Zhai D; Song L; Cai Z; Yu C
J Endocrinol; 2019 Jan; ():. PubMed ID: 30650063
[TBL] [Abstract][Full Text] [Related]
10. Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS).
Hurliman A; Keller Brown J; Maille N; Mandala M; Casson P; Osol G
Endocrinology; 2015 Nov; 156(11):4071-80. PubMed ID: 26322372
[TBL] [Abstract][Full Text] [Related]
11. Comparison of steroidogenic pathways among normoandrogenic and hyperandrogenic polycystic ovary syndrome patients and normal cycling women.
Medeiros SF; Barbosa JS; Yamamoto MM
J Obstet Gynaecol Res; 2015 Feb; 41(2):254-63. PubMed ID: 25256274
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
[TBL] [Abstract][Full Text] [Related]
13. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
14. The orphan nuclear receptor NR4A1 regulates transcription of key steroidogenic enzymes in ovarian theca cells.
Li M; Xue K; Ling J; Diao FY; Cui YG; Liu JY
Mol Cell Endocrinol; 2010 May; 319(1-2):39-46. PubMed ID: 20083153
[TBL] [Abstract][Full Text] [Related]
15. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
[TBL] [Abstract][Full Text] [Related]
16. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.
Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E
Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003
[TBL] [Abstract][Full Text] [Related]
17. Androgens in polycystic ovary syndrome: the role of exercise and diet.
Giallauria F; Palomba S; Vigorito C; Tafuri MG; Colao A; Lombardi G; Orio F
Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
[TBL] [Abstract][Full Text] [Related]
18. Obesity and the polycystic ovary syndrome.
Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
de Medeiros SF; Rodgers RJ; Norman RJ
Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
